La salute - Fattore essenziale dello sviluppo

L'azione della DSC nel campo della salute

© dsc

L’azione della DSC nel campo della salute mette in primo piano tre aspetti: il rafforzamento dei sistemi sanitari, la lotta contro le malattie trasmissibili e non trasmissibili e il miglioramento della salute sessuale, riproduttiva, materna, neonatale e infantile. La DSC interviene in Paesi a reddito basso e medio, in contesti stabili o fragili, e in economie in transizione.

Rafforzamento dei sistemi sanitari

Le grandi sfide sono soprattutto la mancanza di personale sanitario, di finanziamenti, di buongoverno e capacità di gestione, la scarsa disponibilità e qualità di infrastruttura, tecnologia e prodotti medici adeguati.

Salute sessuale e riproduttiva

Migliorare la salute delle madri, dei neonati e dei bambini e promuovere una vita sessuale e riproduttiva soddisfacente e senza rischi.

Malattie non trasmissibili e trasmissibili

Mettere in atto strategie per la promozione di uno stile di vita sano, la prevenzione, la diagnosi e il trattamento delle malattie non trasmissibili; sostenere la prevenzione, il trattamento e la ricerca di nuovi farmaci e strumenti diagnostici contro le malattie tropicali trascurate, la malaria, la tubercolosi, l’AIDS, la diarrea e i disturbi respiratori acuti.

Documenti

Progetti attuali

Oggetto 25 – 36 di 180

Increasing access to patented medicines with the pharmaceutical sector

01.01.2020 - 31.12.2027

2 billion people worldwide do not have access to essential medicines. 50 of these medicines, e.g. for cancer or HIV are patented. The Medicines Patent Pool is a proven mechanism that negotiates with patent holders voluntary licenses for markets in low-income countries which are granted to multiple generic manufacturers. The competition drives down prices but ensures an attractive royalty for the patent holder. SDC supports this voluntary approach to make patented medicines available to people in these countries.


Contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria (GF)

01.01.2020 - 31.12.2022

Health is a precondition, an indicator and a result of sustainable development. The Global Fund (GF) follows the vision of a world free of HIV/AIDS, tuberculosis and malaria. It collects and channels a big share of the international funds dedicated to end these epidemics that disproportionately affect the poorest and most vulnerable people. Its support to country programmes has saved 27 million lives since 2002. In the coming years, the challenge is to maintain this progress and step up the fight to ending the epidemics. 


ESTHER Switzerland (Ensemble pour une Solidarité Thérapeutique Hospitalière En Réseau)

01.12.2019 - 30.11.2024

ESTHER Switzerland provides a mechanism for systematic mobilisation and use of Swiss healthcare expertise to strengthen human resource capacities for health and consequently the quality of service delivery in low and middle-income countries. ESTHER promotes institutional partnerships between Swiss hospitals or research entities with institutions of the same kind in partner countries so as to address priority needs in terms of service delivery.


Dynamic electronic decision trees for managing childhood illness (DYNAMIC)

15.11.2019 - 31.12.2022

Every year, more than five million children die before the age of five due to preventable or treatable causes, most of them in developing countries. New technologies combined with rapid tests can improve diagnosis and management of sick children and reduce health costs. This collaborative research project makes use of Switzerland’s knowledge in digital technologies to improve the health of children and reduce unnecessary antibiotic prescriptions in low resource settings.


Improving Access to Essential Medicines and Basic Technologies for Non-communicable Diseases

01.11.2019 - 31.12.2031

Access to medicines and technologies for non-communicable diseases is poor in low and middle-income countries. Building on the Swiss comparative advantage (broader access engagement as a country with a big pharma sector), the program addresses all components of the comprehensive framework for access to drugs, ranging from research and innovation to dispensing and use. It will also set up a dedicated global collaborative network for advocacy, information and innovation.


Menstrual Health Management (MHM)

15.09.2019 - 31.12.2021

Despite being the majority, young people have the worst HIV outcomes. Evidence-based, demographic and context-adapted responses are essential if ending AIDS by 2030 is to be attained. Proposed is a population level study to determine the impact of a comprehensive community based package of HIV services with a nested sub-study on Menstrual Health Management (MHM). Even though it is often neglected, MHM is crucial for women’s social inclusion, health and gender equality


WHO’s Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN)

01.08.2019 - 31.07.2024

The Expanded Special Project for Elimination of Neglected Tropical Diseases strives to eliminate the five most prevalent neglected tropical diseases in Africa, by providing preventive treatment against e.g. river blindness for free to 600 million people. This continental initiative is carried out by a public-private partnership including pharmaceutical companies. The Swiss contribution makes it possible to accelerate the elimination of the diseases by expanding to more countries and people.


Accountability in Health & Agriculture

01.07.2019 - 30.06.2023

While governments have translated regional policies on Food Security and Sexual and Reproductive Health and Rights (SRHR) into national policies, these are poorly implemented and the public lacks capacities to act effectively upon them. The project will improve the accountability and gender responsiveness of public resource management and complement the ongoing Swiss funded projects in ensuring that policy/advocacy work developed at national, regional and global levels is disseminated and implemented by relevant SADC and governmental institutions.


Global Malaria Technical & Training Support Package (GlobMal)

01.07.2019 - 30.06.2023

The worldwide reduction in malaria-related death in the last two decades is a major global public health success. Despite the 6 million lives saved from malaria, still more than 400’000 people die every year. The project aims to shape effective global and national malaria control and elimination strategies, by providing the necessary scientific evidence and strengthening capacities of malaria-affected countries. Swiss research and private sector contribute to the design and implementation of these global and national malaria strategies.


Ifakara Health Institute: Scaling up of research results and innovations to maximize public health impact

15.06.2019 - 14.06.2022

Investment in health research and innovation in Tanzania is a national policy priority but receives irregular public support. This contribution aims to strengthen the Ifakara Health Institute, a successful research institution with Swiss roots, to improve its research impact at policy and community levels. The intervention will also bring together researchers and end-users in an innovation hub to identify livelihood challenges of youths and innovative approaches to address these. Private sector partnerships with Swiss innovators will be primary clients of the innovation hub.


Somalia, UNFPA Support to Health, gender and Data.

01.06.2019 - 31.12.2020

The maternal mortality rates in Somalia are among the highest in the world, which puts women at a high risk in and around child birth. Support to this programme will increase access to sexual and reproductive rights and health services. The programme will also contribute to addressing gender inequality, as well as production of key population data to be used for evidence based programming in Somalia. This will improve women’s well-being, enhance family planning and, as a consequence, increase stability in the region, which is in the Swiss interest.


Reducing risk-factors for Non-Communicable Diseases in Ukraine (opening phase)

01.05.2019 - 31.10.2020

Non-communicable diseases are the main cause of mortality and morbidity in Ukraine incurring significant economic costs of inaction. Non-communicable diseases are determined by risk factors, which can be considerably reduced. This invervention aims at creating a conducive policy and regulatory framework for NCDs prevention, increasing preventive care at primary level and at improving health literacy and reducing behavorial risk factors among the population. 

Oggetto 25 – 36 di 180